| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.5 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.5 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.5 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.032 | 0.5 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.5 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |